|1.||Ho, Tsung-Jung: 2 articles (09/2015 - 06/2015)|
|2.||Lai, Chao-Hung: 2 articles (09/2015 - 06/2015)|
|3.||Huang, Chih-Yang: 2 articles (09/2015 - 06/2015)|
|4.||Yao, Chun-Hsu: 2 articles (09/2015 - 01/2015)|
|5.||Tsai, Chang-Hai: 1 article (09/2015)|
|6.||Tsai, Fuu-Jen: 1 article (09/2015)|
|7.||Han, Chien-Kuo: 1 article (09/2015)|
|8.||Day, Cecilia Hsuan: 1 article (09/2015)|
|9.||Pai, Pei Ying: 1 article (09/2015)|
|10.||Shibu, Marthandam Asokan: 1 article (09/2015)|
09/01/2015 - "Dilong, an edible earthworm extract used in Chinese medicine and its bioactive fibrinolytic enzyme product-lumbrokinase, when administered in rats, restricted the SHS exposure induced cardiac fibrosis and provided cardio-protection. "
04/01/2013 - "Interestingly, lumbrokinase treatment markedly reduced the proteinuria and improved the glomerulosclerosis and tubulointerstitial fibrosis in diabetic rats. "
09/01/2015 - "Lumbrokinase from earthworm extract ameliorates second-hand smoke-induced cardiac fibrosis."
04/01/1993 - "The purpose of the present study is to determine whether lumbrokinase has an in vivo thrombolytic effect in a rabbit cerebral embolism model. "
04/01/1993 - "In our previous studies, we found that lumbrokinase, an extract from Korean earth worms, has a strong in vitro fibrinolytic effect without the presence of plasminogen and significant in vivo thrombolytic effects of lumbrokinase in a rat human-clot-induced cerebral embolism model. "
04/01/1993 - "The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model."
|5.||Diabetic Nephropathies (Diabetic Nephropathy)
04/01/2013 - "The present study was undertaken to investigate the therapeutic effect and underlying mechanisms of lumbrokinase on diabetic nephropathy. "
04/01/2013 - "Lumbrokinase treatment attenuated diabetic nephropathy in rats, possibly through increasing the activity of MMPs and the subsequent degradation of extracellular matrix."
04/01/2013 - "Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats."
|1.||Tobacco Smoke Pollution (Passive Smoking)
|5.||Serine Proteases (Serine Protease)
|10.||Urokinase-Type Plasminogen Activator (Urokinase)